MOLECULAR MECHANISMS OF CORNEAL WOUND HEALING AFTER PHOTO-REFRACTIVE CORNEAL SURGERY
光折射角膜手术后角膜伤口愈合的分子机制
基本信息
- 批准号:11557127
- 负责人:
- 金额:$ 8.64万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B).
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2000
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
After photo-refractive surgery, the corneal wound healing process occurs. Suring this process, the scar is formed and disturbs vision. In this study, we used the corneal wound healing after excimer laser keratectomy model to investigate the new extracellular matrix(ECM)formation. Our focus in this study is the role(s)of transforming growth factor-β(TGF-β)in the ECM formation in wound healing. TGF-β exerts its effects through two types of serine/threonine kinase receptors (type II and I receptors), which activate Smad family signal transducers. Using the cultured cells derived bovine cornea, TGF-β stimulated ECM protein production and hyaluronan synthase(HAS)activity through the pathways including TGF-β receptors and Smad family transducers. In the wound healing process in the excimer laser abrasion model, the corneal epithelial cells surrounding the wound proliferated, migrated and covered the abraded area. Under the regenerated epithelium, keratocytes first disappeared and then re-pop … More ulated the anterior corneal stroma and were involved in the formation of subepithelial ECM formation. In this process, the keratocytes were activated and recruited into the wound site. The activated keratocytes and abnormal ECM thereafter disappeared during tissue remodelling. During the wound healing process, the expression of 3 TGF-β isoforms(TGF-β1, β2, β3), 2 types of TGF-β receptors, Smad family members increased in the regenerating epithelium and the activated keratocytes, which shows that TGF-β is produced and affects wound healing process through the pathways including Smads. These responses were blocked by the treatment with the antibodies neutralizing TGF-β. Blocking effects by antibody to TGF-β1 was modt significant among the isoforms. Taken together, it is spechlated the TGF-β1 is the main player to activate and recruit the keratocytes to produce ECM in the corneal stroma after excimer laser keratectomy, and the functions are different among 3 isoforms. This process was correlated directly with TGF-β, of which the mechanisms remains to be resolved. Less
光折射手术后,角膜伤口会发生愈合过程。在这个过程中,疤痕形成并干扰视力。在本研究中,我们利用准分子激光角膜切除术后角膜伤口愈合模型来研究新的细胞外基质(ECM)的形成。我们本研究的重点是转化生长因子-β (TGF-β) 在伤口愈合中 ECM 形成中的作用。 TGF-β 通过两种类型的丝氨酸/苏氨酸激酶受体(II 型和 I 型受体)发挥作用,激活 Smad 家族信号转导器。使用牛角膜培养细胞,TGF-β 通过 TGF-β 受体和 Smad 家族传感器等途径刺激 ECM 蛋白产生和透明质酸合酶 (HAS) 活性。在准分子激光磨损模型的伤口愈合过程中,伤口周围的角膜上皮细胞增殖、迁移并覆盖磨损区域。在再生的上皮下,角膜细胞首先消失然后重新流行,形成前角膜基质并参与上皮下ECM的形成。在此过程中,角膜细胞被激活并募集到伤口部位。此后,激活的角膜细胞和异常的 ECM 在组织重塑过程中消失。在伤口愈合过程中,再生上皮和活化的角膜细胞中3种TGF-β亚型(TGF-β1、β2、β3)、2种TGF-β受体、Smad家族成员的表达增加,表明TGF-β通过Smads等途径产生并影响伤口愈合过程。这些反应被中和 TGF-β 的抗体治疗所阻断。 TGF-β1 抗体的阻断作用在同工型中最为显着。综上所述,准分子激光角膜切除术后,TGF-β1是激活和募集角膜基质细胞产生ECM的主要参与者,并且3种异构体的功能有所不同。这一过程与TGF-β直接相关,其机制仍有待解决。较少的
项目成果
期刊论文数量(38)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Usui T, Amano S, Oshika T, Suzuki K, Miyata K, Araie M,Heldin P,Yamashita H: "Expression regulation of hyaluronan synthase(HAS)in corneal endothelial cells"Invest Ophthalmol Vis Sci. 41. 3261-3267 (2000)
Usui T、Amano S、Oshika T、Suzuki K、Miyata K、Araie M、Heldin P、Yamashita H:“角膜内皮细胞中透明质酸合酶 (HAS) 的表达调节”Invest Ophasemol Vis Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mita T Yamashita H , Kaji Y , Obata H, Hanyu A, Suzuki M, Tobari I: "Functional difference of TGF-β isoforms regulating corneal wound healing after excimer laser keratectomy"Exp Eye Res. 68. 513-519 (1999)
Mita T Yamashita H、Kaji Y、Obata H、Hanyu A、Suzuki M、Tobari I:“准分子激光角膜切除术后调节角膜伤口愈合的 TGF-β 亚型的功能差异”Exp Eye Res。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Obata H, Yamashita H et al: "Expression of TGF-β superfamily receptors in rat eye."Acta Ophthalmol. 77. 151-156 (1999)
Obata H、Yamashita H 等人:“大鼠眼中 TGF-β 超家族受体的表达”。Acta Ophamol。77. 151-156 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Obata H,Yamashita H et al.: "Expression of TGF-β superfamily receptors in rat eyes."Acta Ophthalmal. 77. 151-156 (1999)
Obata H、Yamashita H 等:“大鼠眼中 TGF-β 超家族受体的表达”。《眼科学报》77. 151-156 (1999)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Obata H, Kaji Y, Yamada H, Kato M, Tsuru T,Yamashita H: "Expression of transforming growth factor-β superfamily receptors in rat eye"Acta Ophthalmol. 77. 151-156 (1999)
Obata H、Kaji Y、Yamada H、Kato M、Tsuru T、Yamashita H:“大鼠眼中转化生长因子-β 超家族受体的表达” Acta Ophamol. 77. 151-156 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAMASHITA Hidetoshi其他文献
Possibilities for Environmental Conservation of Community-Based Renewable Energy Projects
社区可再生能源项目环境保护的可能性
- DOI:
10.5956/jriet.49.3_133 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
我藤諭;山﨑康一郎;水藤昌彦;森久智江;YAMASHITA Hidetoshi - 通讯作者:
YAMASHITA Hidetoshi
マイノリティ言語の保全政策と規範理論
少数民族语言保护政策与规范理论
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
我藤諭;山﨑康一郎;水藤昌彦;森久智江;YAMASHITA Hidetoshi;八十田 博人;辻康夫 - 通讯作者:
辻康夫
YAMASHITA Hidetoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAMASHITA Hidetoshi', 18)}}的其他基金
Comprehensive Social Scientific Study on Radioactive Waste Disposal Issues
放射性废物处置问题的综合社会科学研究
- 批准号:
19H04335 - 财政年份:2019
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular epidemiological study on choroidopathy in diabetic eyes
糖尿病眼脉络膜病变的分子流行病学研究
- 批准号:
18K09439 - 财政年份:2018
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of progression of diabetic retinopathy focusing inflammatory mechanisms by dendritic cells in vitreous
糖尿病视网膜病变进展的分子机制聚焦玻璃体内树突状细胞的炎症机制
- 批准号:
15K10832 - 财政年份:2015
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on policies for the promotion of locally initiated renewable energy projects
地方可再生能源项目促进政策研究
- 批准号:
25281068 - 财政年份:2013
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular pathogenesis and strategic approach of treatment for diabetic retinopathy
糖尿病视网膜病变的分子发病机制及治疗策略
- 批准号:
24592617 - 财政年份:2012
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New strategy to treat diabetic retinopathy using stabilization of hyalocyte-vasucular endothelial cell correlation
利用稳定透明细胞-血管内皮细胞相关性治疗糖尿病视网膜病变的新策略
- 批准号:
21592215 - 财政年份:2009
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An analysis of the effects of the waste tax on the reduction of the final disposal of industrial wastes
废品税对减少工业废物最终处置量的影响分析
- 批准号:
20710036 - 财政年份:2008
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Changes of retinal vascular structure in diabetic retinopathy andstrategy of treatment
糖尿病视网膜病变视网膜血管结构的变化及治疗策略
- 批准号:
19592004 - 财政年份:2007
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular Mechanisms of Damage to Retinal Neuronal Cells in Diabetic Retinopathy and New Therapeutic Modalities
糖尿病视网膜病变视网膜神经细胞损伤的分子机制及新的治疗方式
- 批准号:
17591819 - 财政年份:2005
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Determination of treatment modalities for diabetic retinopathy and diabetic maculopathy -Strategic approach using molecular and cellular biological methods-
确定糖尿病视网膜病变和糖尿病黄斑病变的治疗方式 -使用分子和细胞生物学方法的策略方法-
- 批准号:
15591841 - 财政年份:2003
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Assessment of dynamic movement and transfection efficiency of mRNA lipid nanoparticles in human iPSC-derived cornea-on-a-chip
人 iPSC 衍生角膜芯片中 mRNA 脂质纳米颗粒的动态运动和转染效率评估
- 批准号:
24K15712 - 财政年份:2024
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A human tissue-engineered three-layer cornea (hTEC) supplemented with macrophages as a biomaterial for in vitro studies
补充有巨噬细胞的人体组织工程三层角膜(hTEC)作为体外研究的生物材料
- 批准号:
488980 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Operating Grants
Development of next-generation hybrid full-thickness cornea preparation and preservation method
下一代混合全层角膜制备和保存方法的开发
- 批准号:
23K09047 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vivo high-resolution mapping of the elastic moduli and tensile stress in the human cornea
人体角膜弹性模量和拉应力的体内高分辨率绘图
- 批准号:
10633769 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
A single dose anti-scarring therapeutic for the cornea
单剂量角膜抗疤痕治疗剂
- 批准号:
10697582 - 财政年份:2023
- 资助金额:
$ 8.64万 - 项目类别:
In vivo optical coherence elastography of the cornea: mapping shear and tensile moduli
角膜体内光学相干弹性成像:绘制剪切模量和拉伸模量
- 批准号:
10706960 - 财政年份:2022
- 资助金额:
$ 8.64万 - 项目类别:
2022 Cornea and Ocular Surface Biology, Pathology and Regeneration GRC/GRS
2022 角膜和眼表面生物学、病理学和再生 GRC/GRS
- 批准号:
10377627 - 财政年份:2022
- 资助金额:
$ 8.64万 - 项目类别:
The Role of AP-2ß in the Development of Limbal Epithelial Stem Cells and the Cornea
AP-2™ 在角膜缘上皮干细胞和角膜发育中的作用
- 批准号:
490916 - 财政年份:2022
- 资助金额:
$ 8.64万 - 项目类别:
Studentship Programs
Spatiotemporal metabolomics analysis in the human cornea-on-a-chip for the determination of ocular drug toxicity
人角膜芯片时空代谢组学分析用于测定眼部药物毒性
- 批准号:
22K14548 - 财政年份:2022
- 资助金额:
$ 8.64万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
In vivo optical coherence elastography of the cornea: mapping shear and tensile moduli
角膜体内光学相干弹性成像:绘制剪切模量和拉伸模量
- 批准号:
10344917 - 财政年份:2022
- 资助金额:
$ 8.64万 - 项目类别:














{{item.name}}会员




